Predictive DNA damage signaling for low‑dose ionizing radiation.

Area of Science:

• Biomedical Sciences
• Radiation Biology
• Molecular Biology

Background:

• Developing reliable biological markers for radiation response is crucial for accurate assessment.
• Existing methods often lack broad applicability in radiation research.
• Identifying sensitive markers for low-dose radiation is a significant challenge.

Purpose of the Study:

• To identify and validate novel biological markers for low-dose radiation sensitivity.
• To investigate the role of DNA damage repair, cell cycle regulation, and cytokine signaling molecules.
• To explore potential radioprotective agents and their mechanisms.

Main Methods:

• Analysis of public databases to select candidate molecules.
• Irradiation of cell lines (HuT 78, IM-9) and human peripheral blood mononuclear cells.
• Western blot analysis to assess protein expression and activation (ATM, CHK2, p53, H2AX).
• In vivo studies in mice to evaluate radioprotective effects of cinobufagin.
• Assessment of apoptosis and modulation of radiation-induced cell death using specific inhibitors (KU60019, BML-277, pifithrin-α, nutlin-3a).

Main Results:

• Activation of ATM, CHK2, p53, and H2AX increased in a concentration-dependent manner following irradiation.
• Cinobufagin showed a trend towards radioprotective effects in mice, increasing bone marrow cells and survival.
• BML-277 reduced radiation-induced p-CHK2 and γH2AX levels, mitigating apoptosis.

Conclusions:

• Selected molecules involved in DNA damage repair and cell cycle regulation serve as promising low-dose radiation-sensitive markers.
• These markers can aid in predicting radiation exposure and assessing associated human health risks.
• The study provides a foundation for developing new drug candidates targeting radiation response pathways.